Effect of age on hemoglobin levels and quality of life following treatment with epoetin alfa in cancer patients
Fabio Puglisi(University of Udine), Patrizia Beccaglia(Janssen (Italy)), Laura Deroma(University of Udine), Giacomo Cartenì(Ospedale Antonio Cardarelli), Salvatore Del Prete(Federico II University Hospital), G. Ucci(Alessandro Manzoni Hospital), Stefania Russo(National Center for Oncological Hadrontherapy), Andrea Sporchia(Daiichi Sankyo (United States)), Graziella Pinotti(Medica (Italy)), Giorgio De Signoribus(Sapienza University of Rome)
Cited by 7
Related Papers
Phase III Study of Bevacizumab Plus Docetaxel Compared With Placebo Plus Docetaxel for the First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer
|Journal of Clinical Oncology|2010|887
Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer
|New England Journal of Medicine|2014|751
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
|New England Journal of Medicine|2018|684